Global Type 2 Diabetes Therapeutics Market Size, Status and Forecast 2021-2027

2型糖尿病治療薬の世界市場規模・現状・予測2021年-2027年

◆タイトル:Global Type 2 Diabetes Therapeutics Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR5771
◆調査・発行会社:QYResearch
◆発行日:2021年4月
◆ページ数:91
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、主要地域
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥429,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥643,500見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥858,000見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査資料では、2型糖尿病治療薬の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(DPP-4阻害剤、ビグアニド、インスリン、SGLT-2阻害剤、α-グルコシダーゼ阻害剤、その他)、用途別市場規模(子供、中年層、高齢者)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・2型糖尿病治療薬の市場動向
・企業の競争状況、市場シェア
・2型糖尿病治療薬の種類別市場規模(DPP-4阻害剤、ビグアニド、インスリン、SGLT-2阻害剤、α-グルコシダーゼ阻害剤、その他)
・2型糖尿病治療薬の用途別市場規模(子供、中年層、高齢者)
・2型糖尿病治療薬の北米市場規模2016-2027(アメリカ、カナダ)
・2型糖尿病治療薬の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・2型糖尿病治療薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・2型糖尿病治療薬の中南米市場規模2016-2027(メキシコ、ブラジル)
・2型糖尿病治療薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(AstraZeneca、Novartis、Novo Nordisk、Boehringer Ingelheim、Bristol-Myers Squibb、Eli Lilly、Merck、Sanofi)
・結論

Market Analysis and Insights: Global Type 2 Diabetes Therapeutics Market
The global Type 2 Diabetes Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Type 2 Diabetes Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Type 2 Diabetes Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Type 2 Diabetes Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Type 2 Diabetes Therapeutics market.

Global Type 2 Diabetes Therapeutics Scope and Market Size
Type 2 Diabetes Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Type 2 Diabetes Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
DPP-4 Inhibitors
Biguanides
Insulins
SGLT-2 Inhibitors
α-Glucosidase Inhibitors
Other

Segment by Application
Children
Middle-Aged Person
Aged

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca
Novartis
Novo Nordisk
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly
Merck
Sanofi

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Type 2 Diabetes Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 DPP-4 Inhibitors
1.2.3 Biguanides
1.2.4 Insulins
1.2.5 SGLT-2 Inhibitors
1.2.6 α-Glucosidase Inhibitors
1.2.7 Other
1.3 Market by Application
1.3.1 Global Type 2 Diabetes Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Children
1.3.3 Middle-Aged Person
1.3.4 Aged
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Type 2 Diabetes Therapeutics Market Perspective (2016-2027)
2.2 Type 2 Diabetes Therapeutics Growth Trends by Regions
2.2.1 Type 2 Diabetes Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Type 2 Diabetes Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Type 2 Diabetes Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Type 2 Diabetes Therapeutics Industry Dynamic
2.3.1 Type 2 Diabetes Therapeutics Market Trends
2.3.2 Type 2 Diabetes Therapeutics Market Drivers
2.3.3 Type 2 Diabetes Therapeutics Market Challenges
2.3.4 Type 2 Diabetes Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Type 2 Diabetes Therapeutics Players by Revenue
3.1.1 Global Top Type 2 Diabetes Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Type 2 Diabetes Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Type 2 Diabetes Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Type 2 Diabetes Therapeutics Revenue
3.4 Global Type 2 Diabetes Therapeutics Market Concentration Ratio
3.4.1 Global Type 2 Diabetes Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Type 2 Diabetes Therapeutics Revenue in 2020
3.5 Type 2 Diabetes Therapeutics Key Players Head office and Area Served
3.6 Key Players Type 2 Diabetes Therapeutics Product Solution and Service
3.7 Date of Enter into Type 2 Diabetes Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Type 2 Diabetes Therapeutics Breakdown Data by Type
4.1 Global Type 2 Diabetes Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Type 2 Diabetes Therapeutics Forecasted Market Size by Type (2022-2027)

5 Type 2 Diabetes Therapeutics Breakdown Data by Application
5.1 Global Type 2 Diabetes Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Type 2 Diabetes Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Type 2 Diabetes Therapeutics Market Size (2016-2027)
6.2 North America Type 2 Diabetes Therapeutics Market Size by Type
6.2.1 North America Type 2 Diabetes Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Type 2 Diabetes Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Type 2 Diabetes Therapeutics Market Size by Type (2016-2027)
6.3 North America Type 2 Diabetes Therapeutics Market Size by Application
6.3.1 North America Type 2 Diabetes Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Type 2 Diabetes Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Type 2 Diabetes Therapeutics Market Size by Application (2016-2027)
6.4 North America Type 2 Diabetes Therapeutics Market Size by Country
6.4.1 North America Type 2 Diabetes Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Type 2 Diabetes Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Type 2 Diabetes Therapeutics Market Size (2016-2027)
7.2 Europe Type 2 Diabetes Therapeutics Market Size by Type
7.2.1 Europe Type 2 Diabetes Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Type 2 Diabetes Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Type 2 Diabetes Therapeutics Market Size by Type (2016-2027)
7.3 Europe Type 2 Diabetes Therapeutics Market Size by Application
7.3.1 Europe Type 2 Diabetes Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Type 2 Diabetes Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Type 2 Diabetes Therapeutics Market Size by Application (2016-2027)
7.4 Europe Type 2 Diabetes Therapeutics Market Size by Country
7.4.1 Europe Type 2 Diabetes Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Type 2 Diabetes Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Type 2 Diabetes Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Type 2 Diabetes Therapeutics Market Size by Type
8.2.1 Asia-Pacific Type 2 Diabetes Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Type 2 Diabetes Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Type 2 Diabetes Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Type 2 Diabetes Therapeutics Market Size by Application
8.3.1 Asia-Pacific Type 2 Diabetes Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Type 2 Diabetes Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Type 2 Diabetes Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Type 2 Diabetes Therapeutics Market Size by Region
8.4.1 Asia-Pacific Type 2 Diabetes Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Type 2 Diabetes Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Type 2 Diabetes Therapeutics Market Size (2016-2027)
9.2 Latin America Type 2 Diabetes Therapeutics Market Size by Type
9.2.1 Latin America Type 2 Diabetes Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Type 2 Diabetes Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Type 2 Diabetes Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Type 2 Diabetes Therapeutics Market Size by Application
9.3.1 Latin America Type 2 Diabetes Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Type 2 Diabetes Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Type 2 Diabetes Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Type 2 Diabetes Therapeutics Market Size by Country
9.4.1 Latin America Type 2 Diabetes Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Type 2 Diabetes Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Type 2 Diabetes Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Type 2 Diabetes Therapeutics Market Size by Type
10.2.1 Middle East & Africa Type 2 Diabetes Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Type 2 Diabetes Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Type 2 Diabetes Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Type 2 Diabetes Therapeutics Market Size by Application
10.3.1 Middle East & Africa Type 2 Diabetes Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Type 2 Diabetes Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Type 2 Diabetes Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Type 2 Diabetes Therapeutics Market Size by Country
10.4.1 Middle East & Africa Type 2 Diabetes Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Type 2 Diabetes Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Type 2 Diabetes Therapeutics Introduction
11.1.4 AstraZeneca Revenue in Type 2 Diabetes Therapeutics Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Type 2 Diabetes Therapeutics Introduction
11.2.4 Novartis Revenue in Type 2 Diabetes Therapeutics Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Details
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Type 2 Diabetes Therapeutics Introduction
11.3.4 Novo Nordisk Revenue in Type 2 Diabetes Therapeutics Business (2016-2021)
11.3.5 Novo Nordisk Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Details
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Type 2 Diabetes Therapeutics Introduction
11.4.4 Boehringer Ingelheim Revenue in Type 2 Diabetes Therapeutics Business (2016-2021)
11.4.5 Boehringer Ingelheim Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Type 2 Diabetes Therapeutics Introduction
11.5.4 Bristol-Myers Squibb Revenue in Type 2 Diabetes Therapeutics Business (2016-2021)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Type 2 Diabetes Therapeutics Introduction
11.6.4 Eli Lilly Revenue in Type 2 Diabetes Therapeutics Business (2016-2021)
11.6.5 Eli Lilly Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Type 2 Diabetes Therapeutics Introduction
11.7.4 Merck Revenue in Type 2 Diabetes Therapeutics Business (2016-2021)
11.7.5 Merck Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Type 2 Diabetes Therapeutics Introduction
11.8.4 Sanofi Revenue in Type 2 Diabetes Therapeutics Business (2016-2021)
11.8.5 Sanofi Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Type 2 Diabetes Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of DPP-4 Inhibitors
Table 3. Key Players of Biguanides
Table 4. Key Players of Insulins
Table 5. Key Players of SGLT-2 Inhibitors
Table 6. Key Players of α-Glucosidase Inhibitors
Table 7. Key Players of Other
Table 8. Global Type 2 Diabetes Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Type 2 Diabetes Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Type 2 Diabetes Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Type 2 Diabetes Therapeutics Market Share by Regions (2016-2021)
Table 12. Global Type 2 Diabetes Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Type 2 Diabetes Therapeutics Market Share by Regions (2022-2027)
Table 14. Type 2 Diabetes Therapeutics Market Trends
Table 15. Type 2 Diabetes Therapeutics Market Drivers
Table 16. Type 2 Diabetes Therapeutics Market Challenges
Table 17. Type 2 Diabetes Therapeutics Market Restraints
Table 18. Global Type 2 Diabetes Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Type 2 Diabetes Therapeutics Market Share by Players (2016-2021)
Table 20. Global Top Type 2 Diabetes Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Type 2 Diabetes Therapeutics as of 2020)
Table 21. Ranking of Global Top Type 2 Diabetes Therapeutics Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Type 2 Diabetes Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Type 2 Diabetes Therapeutics Product Solution and Service
Table 25. Date of Enter into Type 2 Diabetes Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Type 2 Diabetes Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Type 2 Diabetes Therapeutics Revenue Market Share by Type (2016-2021)
Table 29. Global Type 2 Diabetes Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Type 2 Diabetes Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Type 2 Diabetes Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Type 2 Diabetes Therapeutics Revenue Market Share by Application (2016-2021)
Table 33. Global Type 2 Diabetes Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Type 2 Diabetes Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Type 2 Diabetes Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Type 2 Diabetes Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Type 2 Diabetes Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Type 2 Diabetes Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Type 2 Diabetes Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Type 2 Diabetes Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Type 2 Diabetes Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Type 2 Diabetes Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Type 2 Diabetes Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Type 2 Diabetes Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Type 2 Diabetes Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Type 2 Diabetes Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Type 2 Diabetes Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Type 2 Diabetes Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Type 2 Diabetes Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Type 2 Diabetes Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Type 2 Diabetes Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Type 2 Diabetes Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Type 2 Diabetes Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Type 2 Diabetes Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Type 2 Diabetes Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Type 2 Diabetes Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Type 2 Diabetes Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Type 2 Diabetes Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Type 2 Diabetes Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Type 2 Diabetes Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Type 2 Diabetes Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Type 2 Diabetes Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Type 2 Diabetes Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Type 2 Diabetes Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 65. AstraZeneca Company Details
Table 66. AstraZeneca Business Overview
Table 67. AstraZeneca Type 2 Diabetes Therapeutics Product
Table 68. AstraZeneca Revenue in Type 2 Diabetes Therapeutics Business (2016-2021) & (US$ Million)
Table 69. AstraZeneca Recent Development
Table 70. Novartis Company Details
Table 71. Novartis Business Overview
Table 72. Novartis Type 2 Diabetes Therapeutics Product
Table 73. Novartis Revenue in Type 2 Diabetes Therapeutics Business (2016-2021) & (US$ Million)
Table 74. Novartis Recent Development
Table 75. Novo Nordisk Company Details
Table 76. Novo Nordisk Business Overview
Table 77. Novo Nordisk Type 2 Diabetes Therapeutics Product
Table 78. Novo Nordisk Revenue in Type 2 Diabetes Therapeutics Business (2016-2021) & (US$ Million)
Table 79. Novo Nordisk Recent Development
Table 80. Boehringer Ingelheim Company Details
Table 81. Boehringer Ingelheim Business Overview
Table 82. Boehringer Ingelheim Type 2 Diabetes Therapeutics Product
Table 83. Boehringer Ingelheim Revenue in Type 2 Diabetes Therapeutics Business (2016-2021) & (US$ Million)
Table 84. Boehringer Ingelheim Recent Development
Table 85. Bristol-Myers Squibb Company Details
Table 86. Bristol-Myers Squibb Business Overview
Table 87. Bristol-Myers Squibb Type 2 Diabetes Therapeutics Product
Table 88. Bristol-Myers Squibb Revenue in Type 2 Diabetes Therapeutics Business (2016-2021) & (US$ Million)
Table 89. Bristol-Myers Squibb Recent Development
Table 90. Eli Lilly Company Details
Table 91. Eli Lilly Business Overview
Table 92. Eli Lilly Type 2 Diabetes Therapeutics Product
Table 93. Eli Lilly Revenue in Type 2 Diabetes Therapeutics Business (2016-2021) & (US$ Million)
Table 94. Eli Lilly Recent Development
Table 95. Merck Company Details
Table 96. Merck Business Overview
Table 97. Merck Type 2 Diabetes Therapeutics Product
Table 98. Merck Revenue in Type 2 Diabetes Therapeutics Business (2016-2021) & (US$ Million)
Table 99. Merck Recent Development
Table 100. Sanofi Company Details
Table 101. Sanofi Business Overview
Table 102. Sanofi Revenue in Type 2 Diabetes Therapeutics Business (2016-2021) & (US$ Million)
Table 103. Sanofi Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Type 2 Diabetes Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. DPP-4 Inhibitors Features
Figure 3. Biguanides Features
Figure 4. Insulins Features
Figure 5. SGLT-2 Inhibitors Features
Figure 6. α-Glucosidase Inhibitors Features
Figure 7. Other Features
Figure 8. Global Type 2 Diabetes Therapeutics Market Share by Application: 2020 VS 2027
Figure 9. Children Case Studies
Figure 10. Middle-Aged Person Case Studies
Figure 11. Aged Case Studies
Figure 12. Type 2 Diabetes Therapeutics Report Years Considered
Figure 13. Global Type 2 Diabetes Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Type 2 Diabetes Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Type 2 Diabetes Therapeutics Market Share by Regions: 2020 VS 2027
Figure 16. Global Type 2 Diabetes Therapeutics Market Share by Regions (2022-2027)
Figure 17. Global Type 2 Diabetes Therapeutics Market Share by Players in 2020
Figure 18. Global Top Type 2 Diabetes Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Type 2 Diabetes Therapeutics as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Type 2 Diabetes Therapeutics Revenue in 2020
Figure 20. Global Type 2 Diabetes Therapeutics Revenue Market Share by Type (2016-2021)
Figure 21. Global Type 2 Diabetes Therapeutics Revenue Market Share by Type (2022-2027)
Figure 22. North America Type 2 Diabetes Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Type 2 Diabetes Therapeutics Market Share by Type (2016-2027)
Figure 24. North America Type 2 Diabetes Therapeutics Market Share by Application (2016-2027)
Figure 25. North America Type 2 Diabetes Therapeutics Market Share by Country (2016-2027)
Figure 26. United States Type 2 Diabetes Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Type 2 Diabetes Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Type 2 Diabetes Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Type 2 Diabetes Therapeutics Market Share by Type (2016-2027)
Figure 30. Europe Type 2 Diabetes Therapeutics Market Share by Application (2016-2027)
Figure 31. Europe Type 2 Diabetes Therapeutics Market Share by Country (2016-2027)
Figure 32. Germany Type 2 Diabetes Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Type 2 Diabetes Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Type 2 Diabetes Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Type 2 Diabetes Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Type 2 Diabetes Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Type 2 Diabetes Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Type 2 Diabetes Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Type 2 Diabetes Therapeutics Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Type 2 Diabetes Therapeutics Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Type 2 Diabetes Therapeutics Market Share by Region (2016-2027)
Figure 42. China Type 2 Diabetes Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Type 2 Diabetes Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Type 2 Diabetes Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Type 2 Diabetes Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Type 2 Diabetes Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Type 2 Diabetes Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Type 2 Diabetes Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Type 2 Diabetes Therapeutics Market Share by Type (2016-2027)
Figure 50. Latin America Type 2 Diabetes Therapeutics Market Share by Application (2016-2027)
Figure 51. Latin America Type 2 Diabetes Therapeutics Market Share by Country (2016-2027)
Figure 52. Mexico Type 2 Diabetes Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Type 2 Diabetes Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Type 2 Diabetes Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Type 2 Diabetes Therapeutics Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Type 2 Diabetes Therapeutics Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Type 2 Diabetes Therapeutics Market Share by Country (2016-2027)
Figure 58. Turkey Type 2 Diabetes Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Type 2 Diabetes Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Type 2 Diabetes Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. AstraZeneca Revenue Growth Rate in Type 2 Diabetes Therapeutics Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Type 2 Diabetes Therapeutics Business (2016-2021)
Figure 63. Novo Nordisk Revenue Growth Rate in Type 2 Diabetes Therapeutics Business (2016-2021)
Figure 64. Boehringer Ingelheim Revenue Growth Rate in Type 2 Diabetes Therapeutics Business (2016-2021)
Figure 65. Bristol-Myers Squibb Revenue Growth Rate in Type 2 Diabetes Therapeutics Business (2016-2021)
Figure 66. Eli Lilly Revenue Growth Rate in Type 2 Diabetes Therapeutics Business (2016-2021)
Figure 67. Merck Revenue Growth Rate in Type 2 Diabetes Therapeutics Business (2016-2021)
Figure 68. Sanofi Revenue Growth Rate in Type 2 Diabetes Therapeutics Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[2型糖尿病治療薬の世界市場規模・現状・予測2021年-2027年] (Global Type 2 Diabetes Therapeutics Market Size, Status and Forecast 2021-2027 / QY21APR5771)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆